6533b82cfe1ef96bd128f5d8

RESEARCH PRODUCT

Undertreatment of dyslipidemia: from the Arabian Gulf to the USA. Time to solve this problem!

Rizzo ManfrediNiki KatsikiVasilios G. Athyros

subject

Cardiovascular eventmedicine.medical_specialtybusiness.industryGeneral Medicinemedicine.diseaseMiddle EastCholesterolmedicinePhysical therapyHumansIntensive care medicinebusinessDyslipidemiaApolipoproteins ATriglyceridesApolipoproteins BDyslipidemiasHypolipidemic Agents

description

Undertreatment of dyslipideamia is a universal problem and reduces the efficasy of hypolipidaemic drugs to reduce cardiovascular event rates. The means to face this problem are available and should be utilized to optimize dyslipidaemia control and clinical outcomes.

10.1185/03007995.2014.966189https://pubmed.ncbi.nlm.nih.gov/25233064